Immuno-PET of cancer: A revival of antibody imaging

Journal of Nuclear Medicine

Volumn 52, Issue 8, 2011, Pages 1171-1172

  Boerman, Otto C ^a   Oyen, Wim J G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARCITUMOMAB TC 99M; CAPROMAB PENDETIDE IN 111; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; GALLIUM 68; IBRITUMOMAB TIUXETAN; IODINE 124; LUTETIUM 177; MONOCLONAL ANTIBODY A 33 I 124; MONOCLONAL ANTIBODY B.72.3; NOFETUMOMAB MERPENTAN TC 99M; ONCOSCINT; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; TRASTUZUMAB; UNCLASSIFIED DRUG; YTTRIUM 90; ZIRCONIUM 89;

BREAST CANCER; CANCER STAGING; COLORECTAL CARCINOMA; DIAGNOSTIC ACCURACY; DOSIMETRY; DRUG RESEARCH; HUMAN; IMAGE QUALITY; IMMUNOHISTOCHEMISTRY; ISOTOPE LABELING; LUNG SMALL CELL CANCER; MALIGNANT NEOPLASTIC DISEASE; MEDICAL DECISION MAKING; OVARY CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; RADIOIMMUNOTHERAPY; REVIEW; SENSITIVITY AND SPECIFICITY;

ANTIBODIES; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; HUMANS; IMMUNE SYSTEM; IODINE RADIOISOTOPES; MEDICAL ONCOLOGY; MEMBRANE GLYCOPROTEINS; MOLECULAR IMAGING; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOIMMUNOTHERAPY;

EID: 80051682063     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.111.089771     Document Type: Review

References (17)

1. Mach JP, Carrel S, Merenda C, Sordat B, Cerottini JC. In vivo localisation of radiolabelled antibodies to carcinoembryonic antigen in human colon carcinoma grafted into nude mice. Nature. 1974;248:704-706.
2. Goldenberg DM, DeLand F, Kim E, et al. Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med. 1978;298:1384-1386.
3. 124I-huA33 antibody PET of colorectal cancer. J Nucl Med. 2011;52:1173-1180.
4. 131I-huA33 in patients with advanced colorectal carcinoma. Clin Cancer Res. 2005;11:4818-4826.
5. Scott AM, Lee FT, Jones R, et al. A phase I trial of humanized monoclonal antibody A33 in patients with colorectal carcinoma: biodistribution, pharmacokinetics, and quantitative tumor uptake. Clin Cancer Res. 2005;11:4810-4817. (Pubitemid 41568167)
6. 124I-cG250) and PET in patients with renal masses: a phase I trial. Lancet Oncol. 2007;8:304-310.
7. Pre-surgical detection of clear cell renal cell carcinoma using radiolabeled G250-antibody. Clinical-Trials.gov Web site. Available at: www.clinicaltrials.gov/ct2/show/NCT00606632. Published January 21, Updated September 10, 2009. Accessed June 8, 2011.
8. Phase III registration trial: REDECT. Wilex Web site. Available at: www.wilex.de/R&D/Redectane-PhaseIII.htm. Accessed June 8, 2011.
9. 90Y-Zevalin biodistribution with positron emission tomography. Eur J Nucl Med Mol Imaging. 2006;33:1337-1345.
10. 177Lu in tumorbearing nude mice after coupling to the internalizing antibody cetuximab. J Nucl Med. 2005;46:1898-1906.
11. 89Zr-trastuzumab and PET imaging of HER2-positive lesions in patients with metastatic breast cancer. Clin Pharmacol Ther. 2010;87:586-592.
12. Olafsen T, Wu AM. Antibody vectors for imaging. Semin Nucl Med. 2010;40:167-181.
13. Ahlgren S, Tolmachev V. Radionuclide molecular imaging using Affibody molecules. Curr Pharm Biotechnol. 2010;11:581-589.
14. 68Ga-labeled Affibody molecules. J Nucl Med. 2010;51:892-897.
15. 124I-labeled hapten-peptide. J Nucl Med. 2006;47:1678-1688.
16. Sharkey RM, Karacay H, Vallabhajosula S, et al. Metastatic human colonic carcinoma: molecular imaging with pretargeted SPECT and PET in a mouse model. Radiology. 2008;246:497-507.
17. 18F-labeled hapten peptide in mice with human tumor xenografts. Mol Cancer Ther. 2010;9:1019-1027.